The emergence of drug transporter-mediated multidrug resistance to cancer chemotherapy

Molecular Pharmaceutics

Volumn 8, Issue 6, 2011, Pages 1996-2011

  Wu, Chung Pu ^a   Hsieh, Chia Hung ^b   Wu, Yu Shan ^c  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c TUNGHAI UNIVERSITY   (Taiwan)

Author keywords

ABC transporter; cancer; multidrug resistance; tumor microenvironment

Indexed keywords

7 ETHYL 10 HYDROXYCAMPTOTHECIN; ADEFOVIR; ARSENIC TRIOXIDE; BIRICODAR; BREAST CANCER RESISTANCE PROTEIN; CARRIER PROTEIN; CYTARABINE; DASATINIB; DOCETAXEL; EPIRUBICIN; ETOPOSIDE; FLAVOPIRIDOL; GEMCITABINE; GLYCOPROTEIN P; IMATINIB; IRINOTECAN; LAPATINIB; MELPHALAN; METHOTREXATE; MITOMYCIN C; MITOXANTRONE; MULTIDRUG RESISTANCE PROTEIN 1; PACLITAXEL; SAQUINAVIR; TARIQUIDAR; TOPOTECAN; UNINDEXED DRUG; VINCRISTINE; ZALCITABINE; ZOSUQUIDAR;

ARTICLE; CANCER CHEMOTHERAPY; CANCER STEM CELL; HUMAN; METASTASIS; MULTIDRUG RESISTANCE; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SOLID TUMOR; UPREGULATION;

ATP-BINDING CASSETTE TRANSPORTERS; DRUG RESISTANCE, MULTIPLE; HUMANS; MODELS, BIOLOGICAL; NEOPLASMS;

EID: 82955229539     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp200261n     Document Type: Article

References (245)

1. Lage, H. An overview of cancer multidrug resistance: a still unsolved problem Cell. Mol. Life Sci. 2008, 65 (20) 3145-67
2. Mellor, H. R.; Callaghan, R. Resistance to chemotherapy in cancer: a complex and integrated cellular response Pharmacology 2008, 81 (4) 275-300 (Pubitemid 351666917)
3. Gillet, J. P.; Gottesman, M. M. Mechanisms of multidrug resistance in cancer Methods Mol. Biol. (Clifton, N.J.) 2010, 596, 47-76
4. Szakacs, G.; Paterson, J. K.; Ludwig, J. A.; Booth-Genthe, C.; Gottesman, M. M. Targeting multidrug resistance in cancer Nat. Rev. 2006, 5 (3) 219-34 (Pubitemid 43336035)
5. Cho, K.; Wang, X.; Nie, S.; Chen, Z. G.; Shin, D. M. Therapeutic nanoparticles for drug delivery in cancer Clin. Cancer Res. 2008, 14 (5) 1310-6 (Pubitemid 351413909)
6. Ambudkar, S. V.; Dey, S.; Hrycyna, C. A.; Ramachandra, M.; Pastan, I.; Gottesman, M. M. Biochemical, cellular, and pharmacological aspects of the multidrug transporter Annu. Rev. Pharmacol. Toxicol. 1999, 39, 361-98 (Pubitemid 29222564)
7. Dano, K. Active outward transport of daunomycin in resistant Ehrlich ascites tumor cells Biochim. Biophys. Acta 1973, 323 (3) 466-83
8. Juliano, R. L.; Ling, V. A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants Biochim. Biophys. Acta 1976, 455 (1) 152-62
9. Beck, W. T.; Mueller, T. J.; Tanzer, L. R. Altered surface membrane glycoproteins in Vinca alkaloid-resistant human leukemic lymphoblasts Cancer Res. 1979, 39 (6 Pt 1) 2070-6 (Pubitemid 9185002)
10. Riordan, J. R.; Ling, V. Purification of P-glycoprotein from plasma membrane vesicles of Chinese hamster ovary cell mutants with reduced colchicine permeability J. Biol. Chem. 1979, 254 (24) 12701-5 (Pubitemid 10137661)
11. Higgins, C. F. ABC transporters: from microorganisms to man Annu. Rev. Cell Biol. 1992, 8, 67-113 (Pubitemid 23000992)
12. Gottesman, M. M.; Ambudkar, S. V. Overview: ABC transporters and human disease J. Bioenerg. Biomembr. 2001, 33 (6) 453-8 (Pubitemid 34052570)
13. Gottesman, M. M.; Fojo, T.; Bates, S. E. Multidrug resistance in cancer: role of ATP-dependent transporters Nat. Rev. Cancer 2002, 2 (1) 48-58 (Pubitemid 37328807)
14. Tsuruo, T.; Iida, H.; Tsukagoshi, S.; Sakurai, Y. Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil Cancer Res. 1981, 41 (5) 1967-72 (Pubitemid 11114605)
15. Shukla, S.; Wu, C. P.; Ambudkar, S. V. Development of inhibitors of ATP-binding cassette drug transporters: present status and challenges Expert Opin. Drug Metab. Toxicol. 2008, 4 (2) 205-23 (Pubitemid 351308418)
16. Riordan, J. R.; Deuchars, K.; Kartner, N.; Alon, N.; Trent, J.; Ling, V. Amplification of P-glycoprotein genes in multidrug-resistant mammalian cell lines Nature 1985, 316 (6031) 817-9 (Pubitemid 15003740)
17. Roninson, I. B.; Chin, J. E.; Choi, K. G.; Gros, P.; Housman, D. E.; Fojo, A.; Shen, D. W.; Gottesman, M. M.; Pastan, I. Isolation of human mdr DNA sequences amplified in multidrug-resistant KB carcinoma cells Proc. Natl. Acad. Sci. U.S.A. 1986, 83 (12) 4538-42 (Pubitemid 16057084)
18. Shen, D. W.; Fojo, A.; Chin, J. E.; Roninson, I. B.; Richert, N.; Pastan, I.; Gottesman, M. M. Human multidrug-resistant cell lines: increased mdr1 expression can precede gene amplification Science (New York, N.Y.) 1986, 232 (4750) 643-5 (Pubitemid 16061975)
19. Fojo, A. T.; Ueda, K.; Slamon, D. J.; Poplack, D. G.; Gottesman, M. M.; Pastan, I. Expression of a multidrug-resistance gene in human tumors and tissues Proc. Natl. Acad. Sci. U.S.A. 1987, 84 (1) 265-9 (Pubitemid 17013615)
20. Ueda, K.; Cornwell, M. M.; Gottesman, M. M.; Pastan, I.; Roninson, I. B.; Ling, V.; Riordan, J. R. The mdr1 gene, responsible for multidrug-resistance, codes for P-glycoprotein Biochem. Biophys. Res. Commun. 1986, 141 (3) 956-62 (Pubitemid 17006141)
21. Bell, D. R.; Gerlach, J. H.; Kartner, N.; Buick, R. N.; Ling, V. Detection of P-glycoprotein in ovarian cancer: a molecular marker associated with multidrug resistance J. Clin. Oncol. 1985, 3 (3) 311-5 (Pubitemid 15131998)
22. Hegedus, T.; Orfi, L.; Seprodi, A.; Varadi, A.; Sarkadi, B.; Keri, G. Interaction of tyrosine kinase inhibitors with the human multidrug transporter proteins, MDR1 and MRP1 Biochim. Biophys. Acta 2002, 1587 (2-3) 318-25 (Pubitemid 34655800)
23. Kim, R. B.; Fromm, M. F.; Wandel, C.; Leake, B.; Wood, A. J.; Roden, D. M.; Wilkinson, G. R. The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors J. Clin. Invest. 1998, 101 (2) 289-94 (Pubitemid 28067324)
24. Norris, M. D.; De Graaf, D.; Haber, M.; Kavallaris, M.; Madafiglio, J.; Gilbert, J.; Kwan, E.; Stewart, B. W.; Mechetner, E. B.; Gudkov, A. V.; Roninson, I. B. Involvement of MDR1 P-glycoprotein in multifactorial resistance to methotrexate Int. J. Cancer 1996, 65 (5) 613-9 (Pubitemid 26092290)
25. Consoli, U.; Van, N. T.; Neamati, N.; Mahadevia, R.; Beran, M.; Zhao, S.; Andreeff, M. Cellular pharmacology of mitoxantrone in p-glycoprotein-positive and -negative human myeloid leukemic cell lines Leukemia 1997, 11 (12) 2066-74 (Pubitemid 28043691)
26. Van der Bliek, A. M.; Baas, F.; Ten Houte de Lange, T.; Kooiman, P. M.; Van der Velde-Koerts, T.; Borst, P. The human mdr3 gene encodes a novel P-glycoprotein homologue and gives rise to alternatively spliced mRNAs in liver EMBO J. 1987, 6 (11) 3325-31
27. Thiebaut, F.; Tsuruo, T.; Hamada, H.; Gottesman, M. M.; Pastan, I.; Willingham, M. C. Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues Proc. Natl. Acad. Sci. U.S.A. 1987, 84 (21) 7735-8
28. Thiebaut, F.; Tsuruo, T.; Hamada, H.; Gottesman, M. M.; Pastan, I.; Willingham, M. C. Immunohistochemical localization in normal tissues of different epitopes in the multidrug transport protein P170: evidence for localization in brain capillaries and crossreactivity of one antibody with a muscle protein J. Histochem. Cytochem. 1989, 37 (2) 159-64 (Pubitemid 19039163)
29. Germann, U. A.; Willingham, M. C.; Pastan, I.; Gottesman, M. M. Expression of the human multidrug transporter in insect cells by a recombinant baculovirus Biochemistry 1990, 29 (9) 2295-303 (Pubitemid 20095473)
30. Ambudkar, S. V.; Lelong, I. H.; Zhang, J.; Cardarelli, C. O.; Gottesman, M. M.; Pastan, I. Partial purification and reconstitution of the human multidrug-resistance pump: characterization of the drug-stimulatable ATP hydrolysis Proc. Natl. Acad. Sci. U.S.A. 1992, 89 (18) 8472-6
31. Dey, S.; Ramachandra, M.; Pastan, I.; Gottesman, M. M.; Ambudkar, S. V. Evidence for two nonidentical drug-interaction sites in the human P-glycoprotein Proc. Natl. Acad. Sci. U.S.A. 1997, 94 (20) 10594-9
32. Tatsuta, T.; Naito, M.; Oh-hara, T.; Sugawara, I.; Tsuruo, T. Functional involvement of P-glycoprotein in blood-brain barrier J. Biol. Chem. 1992, 267 (28) 20383-91
33. Schinkel, A. H.; Smit, J. J.; van Tellingen, O.; Beijnen, J. H.; Wagenaar, E.; van Deemter, L.; Mol, C. A.; van der Valk, M. A.; Robanus-Maandag, E. C.; te Riele, H. P. Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs Cell 1994, 77 (4) 491-502 (Pubitemid 24153990)
34. Tishler, D. M.; Weinberg, K. I.; Hinton, D. R.; Barbaro, N.; Annett, G. M.; Raffel, C. MDR1 gene expression in brain of patients with medically intractable epilepsy Epilepsia 1995, 36 (1) 1-6
35. Chan, H. S.; DeBoer, G.; Thiessen, J. J.; Budning, A.; Kingston, J. E.; O'Brien, J. M.; Koren, G.; Giesbrecht, E.; Haddad, G.; Verjee, Z.; Hungerford, J. L.; Ling, V.; Gallie, B. L. Combining cyclosporin with chemotherapy controls intraocular retinoblastoma without requiring radiation Clin. Cancer Res. 1996, 2 (9) 1499-508 (Pubitemid 126447443)
36. Sparreboom, A.; van Asperen, J.; Mayer, U.; Schinkel, A. H.; Smit, J. W.; Meijer, D. K.; Borst, P.; Nooijen, W. J.; Beijnen, J. H.; van Tellingen, O. Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine Proc. Natl. Acad. Sci. U.S.A. 1997, 94 (5) 2031-5 (Pubitemid 27113956)
37. List, A. F.; Kopecky, K. J.; Willman, C. L.; Head, D. R.; Persons, D. L.; Slovak, M. L.; Dorr, R.; Karanes, C.; Hynes, H. E.; Doroshow, J. H.; Shurafa, M.; Appelbaum, F. R. Benefit of cyclosporine modulation of drug resistance in patients with poor-risk acute myeloid leukemia: a Southwest Oncology Group study Blood 2001, 98 (12) 3212-20
38. Siddiqui, A.; Kerb, R.; Weale, M. E.; Brinkmann, U.; Smith, A.; Goldstein, D. B.; Wood, N. W.; Sisodiya, S. M. Association of multidrug resistance in epilepsy with a polymorphism in the drug-transporter gene ABCB1 N. Engl. J. Med. 2003, 348 (15) 1442-8 (Pubitemid 36407173)
39. Hartz, A. M.; Miller, D. S.; Bauer, B. Restoring blood-brain barrier P-glycoprotein reduces brain amyloid-beta in a mouse model of Alzheimer's disease Mol. Pharmacol. 2010, 77 (5) 715-23
40. Sauna, Z. E.; Smith, M. M.; Muller, M.; Kerr, K. M.; Ambudkar, S. V. The mechanism of action of multidrug-resistance-linked P-glycoprotein J. Bioenerg. Biomembr. 2001, 33 (6) 481-91 (Pubitemid 34052574)
41. Aller, S. G.; Yu, J.; Ward, A.; Weng, Y.; Chittaboina, S.; Zhuo, R.; Harrell, P. M.; Trinh, Y. T.; Zhang, Q.; Urbatsch, I. L.; Chang, G. Structure of P-glycoprotein reveals a molecular basis for poly-specific drug binding Science (New York, N.Y.) 2009, 323 (5922) 1718-22
42. Cole, S. P.; Bhardwaj, G.; Gerlach, J. H.; Mackie, J. E.; Grant, C. E.; Almquist, K. C.; Stewart, A. J.; Kurz, E. U.; Duncan, A. M.; Deeley, R. G. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line Science (New York, N.Y.) 1992, 258 (5088) 1650-4 (Pubitemid 23012438)
43. Chang, X. B.; Hou, Y. X.; Riordan, J. R. ATPase activity of purified multidrug resistance-associated protein J. Biol. Chem. 1997, 272 (49) 30962-8 (Pubitemid 27527540)
44. Bakos, E.; Evers, R.; Szakacs, G.; Tusnady, G. E.; Welker, E.; Szabo, K.; de Haas, M.; van Deemter, L.; Borst, P.; Varadi, A.; Sarkadi, B. Functional multidrug resistance protein (MRP1) lacking the N-terminal transmembrane domain J. Biol. Chem. 1998, 273 (48) 32167-75 (Pubitemid 29177162)
45. Hooijberg, J. H.; Pinedo, H. M.; Vrasdonk, C.; Priebe, W.; Lankelma, J.; Broxterman, H. J. The effect of glutathione on the ATPase activity of MRP1 in its natural membranes FEBS Lett. 2000, 469 (1) 47-51 (Pubitemid 30119867)
46. Haimeur, A.; Conseil, G.; Deeley, R. G.; Cole, S. P. Mutations of charged amino acids in or near the transmembrane helices of the second membrane spanning domain differentially affect the substrate specificity and transport activity of the multidrug resistance protein MRP1 (ABCC1) Mol. Pharmacol. 2004, 65 (6) 1375-85 (Pubitemid 38668296)
47. Qin, L.; Zheng, J.; Grant, C. E.; Jia, Z.; Cole, S. P.; Deeley, R. G. Residues responsible for the asymmetric function of the nucleotide binding domains of multidrug resistance protein 1 Biochemistry 2008, 47 (52) 13952-65
48. Jedlitschky, G.; Leier, I.; Buchholz, U.; Center, M.; Keppler, D. ATP-dependent transport of glutathione S-conjugates by the multidrug resistance-associated protein Cancer Res. 1994, 54 (18) 4833-6 (Pubitemid 24289409)
49. Leier, I.; Jedlitschky, G.; Buchholz, U.; Cole, S. P.; Deeley, R. G.; Keppler, D. The MRP gene encodes an ATP-dependent export pump for leukotriene C4 and structurally related conjugates J. Biol. Chem. 1994, 269 (45) 27807-10 (Pubitemid 24354499)
50. Loe, D. W.; Almquist, K. C.; Deeley, R. G.; Cole, S. P. Multidrug resistance protein (MRP)-mediated transport of leukotriene C4 and chemotherapeutic agents in membrane vesicles. Demonstration of glutathione-dependent vincristine transport J. Biol. Chem. 1996, 271 (16) 9675-82
51. Loe, D. W.; Almquist, K. C.; Cole, S. P.; Deeley, R. G. ATP-dependent 17 beta-estradiol 17-(beta-D-glucuronide) transport by multidrug resistance protein (MRP). Inhibition by cholestatic steroids J. Biol. Chem. 1996, 271 (16) 9683-9
52. Flens, M. J.; Zaman, G. J.; van der Valk, P.; Izquierdo, M. A.; Schroeijers, A. B.; Scheffer, G. L.; van der Groep, P.; de Haas, M.; Meijer, C. J.; Scheper, R. J. Tissue distribution of the multidrug resistance protein Am. J. Pathol. 1996, 148 (4) 1237-47 (Pubitemid 26111082)
53. Cole, S. P.; Sparks, K. E.; Fraser, K.; Loe, D. W.; Grant, C. E.; Wilson, G. M.; Deeley, R. G. Pharmacological characterization of multidrug resistant MRP-transfected human tumor cells Cancer Res. 1994, 54 (22) 5902-10 (Pubitemid 24375226)
54. Lautier, D.; Canitrot, Y.; Deeley, R. G.; Cole, S. P. Multidrug resistance mediated by the multidrug resistance protein (MRP) gene Biochem. Pharmacol. 1996, 52 (7) 967-77 (Pubitemid 26338256)
55. Deeley, R. G.; Westlake, C.; Cole, S. P. Transmembrane transport of endo- and xenobiotics by mammalian ATP-binding cassette multidrug resistance proteins Physiol. Rev. 2006, 86 (3) 849-99 (Pubitemid 44033384)
56. Mahon, F. X.; Belloc, F.; Lagarde, V.; Chollet, C.; Moreau-Gaudry, F.; Reiffers, J.; Goldman, J. M.; Melo, J. V. MDR1 gene overexpression confers resistance to imatinib mesylate in leukemia cell line models Blood 2003, 101 (6) 2368-73 (Pubitemid 36304670)
57. Williams, G. C.; Liu, A.; Knipp, G.; Sinko, P. J. Direct evidence that saquinavir is transported by multidrug resistance-associated protein (MRP1) and canalicular multispecific organic anion transporter (MRP2) Antimicrob. Agents Chemother. 2002, 46 (11) 3456-62 (Pubitemid 35192911)
58. Bakos, E.; Evers, R.; Sinko, E.; Varadi, A.; Borst, P.; Sarkadi, B. Interactions of the human multidrug resistance proteins MRP1 and MRP2 with organic anions Mol. Pharmacol. 2000, 57 (4) 760-8 (Pubitemid 30183717)
59. Morrow, C. S.; Peklak-Scott, C.; Bishwokarma, B.; Kute, T. E.; Smitherman, P. K.; Townsend, A. J. Multidrug resistance protein 1 (MRP1, ABCC1) mediates resistance to mitoxantrone via glutathione-dependent drug efflux Mol. Pharmacol. 2006, 69 (4) 1499-505
60. Chu, X. Y.; Suzuki, H.; Ueda, K.; Kato, Y.; Akiyama, S.; Sugiyama, Y. Active efflux of CPT-11 and its metabolites in human KB-derived cell lines The J. Pharmacol. Exp. Ther. 1999, 288 (2) 735-41 (Pubitemid 29119689)
61. Wright, S. R.; Boag, A. H.; Valdimarsson, G.; Hipfner, D. R.; Campling, B. G.; Cole, S. P.; Deeley, R. G. Immunohistochemical detection of multidrug resistance protein in human lung cancer and normal lung Clin. Cancer Res. 1998, 4 (9) 2279-89 (Pubitemid 28415678)
62. Filipits, M.; Suchomel, R. W.; Dekan, G.; Haider, K.; Valdimarsson, G.; Depisch, D.; Pirker, R. MRP and MDR1 gene expression in primary breast carcinomas Clin. Cancer Res. 1996, 2 (7) 1231-7 (Pubitemid 26238456)
63. Kim, S. J.; Ikeda, N.; Shiba, E.; Takamura, Y.; Noguchi, S. Detection of breast cancer micrometastases in peripheral blood using immunomagnetic separation and immunocytochemistry Breast Cancer (Tokyo, Japan) 2001, 8 (1) 63-9
64. Nooter, K.; de la Riviere, G. B.; Klijn, J.; Stoter, G.; Foekens, J. Multidrug resistance protein in recurrent breast cancer Lancet 1997, 349 (9069) 1885-6 (Pubitemid 27270127)
65. St-Pierre, M. V.; Serrano, M. A.; Macias, R. I.; Dubs, U.; Hoechli, M.; Lauper, U.; Meier, P. J.; Marin, J. J. Expression of members of the multidrug resistance protein family in human term placenta Am. J. Physiol. 2000, 279 (4) R1495-503
66. Wijnholds, J.; deLange, E. C.; Scheffer, G. L.; van den Berg, D. J.; Mol, C. A.; van der Valk, M.; Schinkel, A. H.; Scheper, R. J.; Breimer, D. D.; Borst, P. Multidrug resistance protein 1 protects the choroid plexus epithelium and contributes to the blood-cerebrospinal fluid barrier J. Clin. Invest. 2000, 105 (3) 279-85 (Pubitemid 30094447)
67. Doyle, L. A.; Yang, W.; Abruzzo, L. V.; Krogmann, T.; Gao, Y.; Rishi, A. K.; Ross, D. D. A multidrug resistance transporter from human MCF-7 breast cancer cells Proc. Natl. Acad. Sci. U.S.A. 1998, 95 (26) 15665-70 (Pubitemid 29018757)
68. Allikmets, R.; Schriml, L. M.; Hutchinson, A.; Romano-Spica, V.; Dean, M. A human placenta-specific ATP-binding cassette gene (ABCP) on chromosome 4q22 that is involved in multidrug resistance Cancer Res. 1998, 58 (23) 5337-9 (Pubitemid 28551112)
69. McDevitt, C. A.; Collins, R. F.; Conway, M.; Modok, S.; Storm, J.; Kerr, I. D.; Ford, R. C.; Callaghan, R. Purification and 3D structural analysis of oligomeric human multidrug transporter ABCG2 Structure 2006, 14 (11) 1623-32 (Pubitemid 46107268)
70. Litman, T.; Brangi, M.; Hudson, E.; Fetsch, P.; Abati, A.; Ross, D. D.; Miyake, K.; Resau, J. H.; Bates, S. E. The multidrug-resistant phenotype associated with overexpression of the new ABC half-transporter, MXR (ABCG2) J. Cell Sci. 2000, 113 (Part 11) 2011-21 (Pubitemid 30386505)
71. Volk, E. L.; Rohde, K.; Rhee, M.; McGuire, J. J.; Doyle, L. A.; Ross, D. D.; Schneider, E. Methotrexate cross-resistance in a mitoxantrone-selected multidrug-resistant MCF7 breast cancer cell line is attributable to enhanced energy-dependent drug efflux Cancer Res. 2000, 60 (13) 3514-21 (Pubitemid 30482171)
72. Ross, D. D.; Karp, J. E.; Chen, T. T.; Doyle, L. A. Expression of breast cancer resistance protein in blast cells from patients with acute leukemia Blood 2000, 96 (1) 365-8 (Pubitemid 30456496)
73. Sarkadi, B.; Homolya, L.; Szakacs, G.; Varadi, A. Human multidrug resistance ABCB and ABCG transporters: participation in a chemoimmunity defense system Physiol. Rev. 2006, 86 (4) 1179-236 (Pubitemid 44521651)
74. Vlaming, M. L.; Lagas, J. S.; Schinkel, A. H. Physiological and pharmacological roles of ABCG2 (BCRP): recent findings in Abcg2 knockout mice Adv. Drug Delivery Rev. 2009, 61 (1) 14-25
75. Cui, Y.; Konig, J.; Buchholz, J. K.; Spring, H.; Leier, I.; Keppler, D. Drug resistance and ATP-dependent conjugate transport mediated by the apical multidrug resistance protein, MRP2, permanently expressed in human and canine cells Mol. Pharmacol. 1999, 55 (5) 929-37 (Pubitemid 29214613)
76. Huisman, M. T.; Chhatta, A. A.; van Tellingen, O.; Beijnen, J. H.; Schinkel, A. H. MRP2 (ABCC2) transports taxanes and confers paclitaxel resistance and both processes are stimulated by probenecid Int. J. Cancer 2005, 116 (5) 824-9 (Pubitemid 41099717)
77. Ozvegy-Laczka, C.; Koblos, G.; Sarkadi, B.; Varadi, A. Single amino acid (482) variants of the ABCG2 multidrug transporter: major differences in transport capacity and substrate recognition Biochim. Biophys. Acta 2005, 1668 (1) 53-63 (Pubitemid 40164733)
78. Miwa, M.; Tsukahara, S.; Ishikawa, E.; Asada, S.; Imai, Y.; Sugimoto, Y. Single amino acid substitutions in the transmembrane domains of breast cancer resistance protein (BCRP) alter cross resistance patterns in transfectants Int. J. Cancer 2003, 107 (5) 757-63 (Pubitemid 37339729)
79. Yoh, K.; Ishii, G.; Yokose, T.; Minegishi, Y.; Tsuta, K.; Goto, K.; Nishiwaki, Y.; Kodama, T.; Suga, M.; Ochiai, A. Breast cancer resistance protein impacts clinical outcome in platinum-based chemotherapy for advanced non-small cell lung cancer Clin. Cancer Res. 2004, 10 (5) 1691-7 (Pubitemid 38435560)
80. Steinbach, D.; Sell, W.; Voigt, A.; Hermann, J.; Zintl, F.; Sauerbrey, A. BCRP gene expression is associated with a poor response to remission induction therapy in childhood acute myeloid leukemia Leukemia 2002, 16 (8) 1443-7
81. van den Heuvel-Eibrink, M. M.; Wiemer, E. A.; Prins, A.; Meijerink, J. P.; Vossebeld, P. J.; van der Holt, B.; Pieters, R.; Sonneveld, P. Increased expression of the breast cancer resistance protein (BCRP) in relapsed or refractory acute myeloid leukemia (AML) Leukemia 2002, 16 (5) 833-9 (Pubitemid 34537555)
82. Dohse, M.; Scharenberg, C.; Shukla, S.; Robey, R. W.; Volkmann, T.; Deeken, J. F.; Brendel, C.; Ambudkar, S. V.; Neubauer, A.; Bates, S. E. Comparison of ATP-binding cassette transporter interactions with the tyrosine kinase inhibitors imatinib, nilotinib, and dasatinib Drug Metab. Dispos. 2010, 38 (8) 1371-80
83. Dai, C. L.; Tiwari, A. K.; Wu, C. P.; Su, X. D.; Wang, S. R.; Liu, D. G.; Ashby, C. R., Jr.; Huang, Y.; Robey, R. W.; Liang, Y. J.; Chen, L. M.; Shi, C. J.; Ambudkar, S. V.; Chen, Z. S.; Fu, L. W. Lapatinib (Tykerb, GW572016) reverses multidrug resistance in cancer cells by inhibiting the activity of ATP-binding cassette subfamily B member 1 and G member 2 Cancer Res. 2008, 68 (19) 7905-14
84. Wang, X. K.; Fu, L. W. Interaction of tyrosine kinase inhibitors with the MDR- related ABC transporter proteins Curr. Drug Metab. 2010, 11 (7) 618-28
85. Reya, T.; Morrison, S. J.; Clarke, M. F.; Weissman, I. L. Stem cells, cancer, and cancer stem cells Nature 2001, 414 (6859) 105-11 (Pubitemid 33041634)
86. Zhou, S.; Schuetz, J. D.; Bunting, K. D.; Colapietro, A. M.; Sampath, J.; Morris, J. J.; Lagutina, I.; Grosveld, G. C.; Osawa, M.; Nakauchi, H.; Sorrentino, B. P. The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype Nat. Med. 2001, 7 (9) 1028-34 (Pubitemid 32937383)
87. Scharenberg, C. W.; Harkey, M. A.; Torok-Storb, B. The ABCG2 transporter is an efficient Hoechst 33342 efflux pump and is preferentially expressed by immature human hematopoietic progenitors Blood 2002, 99 (2) 507-12 (Pubitemid 34533085)
88. Watanabe, K.; Nishida, K.; Yamato, M.; Umemoto, T.; Sumide, T.; Yamamoto, K.; Maeda, N.; Watanabe, H.; Okano, T.; Tano, Y. Human limbal epithelium contains side population cells expressing the ATP-binding cassette transporter ABCG2 FEBS Lett. 2004, 565 (1-3) 6-10 (Pubitemid 38595311)
89. Islam, M. O.; Kanemura, Y.; Tajria, J.; Mori, H.; Kobayashi, S.; Hara, M.; Yamasaki, M.; Okano, H.; Miyake, J. Functional expression of ABCG2 transporter in human neural stem/progenitor cells Neurosci. Res. 2005, 52 (1) 75-82 (Pubitemid 40461874)
90. Apati, A.; Orban, T. I.; Varga, N.; Nemeth, A.; Schamberger, A.; Krizsik, V.; Erdelyi-Belle, B.; Homolya, L.; Varady, G.; Padanyi, R.; Karaszi, E.; Kemna, E. W.; Nemet, K.; Sarkadi, B. High level functional expression of the ABCG2 multidrug transporter in undifferentiated human embryonic stem cells Biochim. Biophys. Acta 2008, 1778 (12) 2700-9
91. Calcagno, A. M.; Salcido, C. D.; Gillet, J. P.; Wu, C. P.; Fostel, J. M.; Mumau, M. D.; Gottesman, M. M.; Varticovski, L.; Ambudkar, S. V. Prolonged drug selection of breast cancer cells and enrichment of cancer stem cell characteristics J. Natl. Cancer Inst. 2010, 102 (21) 1637-52
92. Visvader, J. E.; Lindeman, G. J. Cancer stem cells in solid tumours: accumulating evidence and unresolved questions Nat. Rev. Cancer 2008, 8 (10) 755-68
93. Vulevic, B.; Chen, Z.; Boyd, J. T.; Davis, W., Jr.; Walsh, E. S.; Belinsky, M. G.; Tew, K. D. Cloning and characterization of human adenosine 5′-triphosphate-binding cassette, sub-family A, transporter 2 (ABCA2) Cancer Res. 2001, 61 (8) 3339-47 (Pubitemid 32695023)
94. Chapuy, B.; Koch, R.; Radunski, U.; Corsham, S.; Cheong, N.; Inagaki, N.; Ban, N.; Wenzel, D.; Reinhardt, D.; Zapf, A.; Schweyer, S.; Kosari, F.; Klapper, W.; Truemper, L.; Wulf, G. G. Intracellular ABC transporter A3 confers multidrug resistance in leukemia cells by lysosomal drug sequestration Leukemia 2008, 22 (8) 1576-86
95. Smith, A. J.; van Helvoort, A.; van Meer, G.; Szabo, K.; Welker, E.; Szakacs, G.; Varadi, A.; Sarkadi, B.; Borst, P. MDR3 P-glycoprotein, a phosphatidylcholine translocase, transports several cytotoxic drugs and directly interacts with drugs as judged by interference with nucleotide trapping J. Biol. Chem. 2000, 275 (31) 23530-9 (Pubitemid 30624635)
96. Frank, N. Y.; Margaryan, A.; Huang, Y.; Schatton, T.; Waaga-Gasser, A. M.; Gasser, M.; Sayegh, M. H.; Sadee, W.; Frank, M. H. ABCB5-mediated doxorubicin transport and chemoresistance in human malignant melanoma Cancer Res. 2005, 65 (10) 4320-33 (Pubitemid 40775671)
97. Childs, S.; Yeh, R. L.; Hui, D.; Ling, V. Taxol resistance mediated by transfection of the liver-specific sister gene of P-glycoprotein Cancer Res. 1998, 58 (18) 4160-7 (Pubitemid 28440574)
98. Zelcer, N.; Saeki, T.; Reid, G.; Beijnen, J. H.; Borst, P. Characterization of drug transport by the human multidrug resistance protein 3 (ABCC3) J. Biol. Chem. 2001, 276 (49) 46400-7
99. Ritter, C. A.; Jedlitschky, G.; Meyer zu Schwabedissen, H.; Grube, M.; Kock, K.; Kroemer, H. K. Cellular export of drugs and signaling molecules by the ATP-binding cassette transporters MRP4 (ABCC4) and MRP5 (ABCC5) Drug Metab. Rev. 2005, 37 (1) 253-78 (Pubitemid 40250291)
100. Belinsky, M. G.; Chen, Z. S.; Shchaveleva, I.; Zeng, H.; Kruh, G. D. Characterization of the drug resistance and transport properties of multidrug resistance protein 6 (MRP6, ABCC6) Cancer Res. 2002, 62 (21) 6172-7 (Pubitemid 35244468)
101. Hopper-Borge, E.; Chen, Z. S.; Shchaveleva, I.; Belinsky, M. G.; Kruh, G. D. Analysis of the drug resistance profile of multidrug resistance protein 7 (ABCC10): resistance to docetaxel Cancer Res. 2004, 64 (14) 4927-30 (Pubitemid 38924539)
102. Chen, Z. S.; Guo, Y.; Belinsky, M. G.; Kotova, E.; Kruh, G. D. Transport of bile acids, sulfated steroids, estradiol 17-beta-D-glucuronide, and leukotriene C4 by human multidrug resistance protein 8 (ABCC11) Mol. Pharmacol. 2005, 67 (2) 545-57 (Pubitemid 40216748)
103. Borst, P.; Evers, R.; Kool, M.; Wijnholds, J. A family of drug transporters: the multidrug resistance-associated proteins J. Natl. Cancer Inst. 2000, 92 (16) 1295-302 (Pubitemid 30662093)
104. Chu, X. Y.; Kato, Y.; Ueda, K.; Suzuki, H.; Niinuma, K.; Tyson, C. A.; Weizer, V.; Dabbs, J. E.; Froehlich, R.; Green, C. E.; Sugiyama, Y. Biliary excretion mechanism of CPT-11 and its metabolites in humans: involvement of primary active transporters Cancer Res. 1998, 58 (22) 5137-43 (Pubitemid 28521174)
105. Dietrich, C. G.; Ottenhoff, R.; de Waart, D. R.; Oude Elferink, R. P. Role of MRP2 and GSH in intrahepatic cycling of toxins Toxicology 2001, 167 (1) 73-81 (Pubitemid 32830948)
106. Chu, X. Y.; Kato, Y.; Niinuma, K.; Sudo, K. I.; Hakusui, H.; Sugiyama, Y. Multispecific organic anion transporter is responsible for the biliary excretion of the camptothecin derivative irinotecan and its metabolites in rats J. Pharmacol. Exp. Ther. 1997, 281 (1) 304-14 (Pubitemid 27203082)
107. Schuetz, J. D.; Connelly, M. C.; Sun, D.; Paibir, S. G.; Flynn, P. M.; Srinivas, R. V.; Kumar, A.; Fridland, A. MRP4: A previously unidentified factor in resistance to nucleoside-based antiviral drugs Nat. Med. 1999, 5 (9) 1048-51 (Pubitemid 29439577)
108. Chen, Z. S.; Lee, K.; Walther, S.; Raftogianis, R. B.; Kuwano, M.; Zeng, H.; Kruh, G. D. Analysis of methotrexate and folate transport by multidrug resistance protein 4 (ABCC4): MRP4 is a component of the methotrexate efflux system Cancer Res. 2002, 62 (11) 3144-50 (Pubitemid 34602407)
109. Jorajuria, S.; Dereuddre-Bosquet, N.; Becher, F.; Martin, S.; Porcheray, F.; Garrigues, A.; Mabondzo, A.; Benech, H.; Grassi, J.; Orlowski, S.; Dormont, D.; Clayette, P. ATP binding cassette multidrug transporters limit the anti-HIV activity of zidovudine and indinavir in infected human macrophages Antiviral Ther. 2004, 9 (4) 519-28 (Pubitemid 39150209)
110. Tian, Q.; Zhang, J.; Tan, T. M.; Chan, E.; Duan, W.; Chan, S. Y.; Boelsterli, U. A.; Ho, P. C.; Yang, H.; Bian, J. S.; Huang, M.; Zhu, Y. Z.; Xiong, W.; Li, X.; Zhou, S. Human multidrug resistance associated protein 4 confers resistance to camptothecins Pharm. Res. 2005, 22 (11) 1837-53 (Pubitemid 41504337)
111. Chen, Z. S.; Lee, K.; Kruh, G. D. Transport of cyclic nucleotides and estradiol 17-beta-D-glucuronide by multidrug resistance protein 4. Resistance to 6-mercaptopurine and 6-thioguanine J. Biol. Chem. 2001, 276 (36) 33747-54
112. Reid, G.; Wielinga, P.; Zelcer, N.; De Haas, M.; Van Deemter, L.; Wijnholds, J.; Balzarini, J.; Borst, P. Characterization of the transport of nucleoside analog drugs by the human multidrug resistance proteins MRP4 and MRP5 Mol. Pharmacol. 2003, 63 (5) 1094-103 (Pubitemid 36529928)
113. Wielinga, P.; Hooijberg, J. H.; Gunnarsdottir, S.; Kathmann, I.; Reid, G.; Zelcer, N.; van der Born, K.; de Haas, M.; van der Heijden, I.; Kaspers, G.; Wijnholds, J.; Jansen, G.; Peters, G.; Borst, P. The human multidrug resistance protein MRP5 transports folates and can mediate cellular resistance against antifolates Cancer Res. 2005, 65 (10) 4425-30 (Pubitemid 40775682)
114. Pratt, S.; Shepard, R. L.; Kandasamy, R. A.; Johnston, P. A.; Perry, W., 3rd; Dantzig, A. H. The multidrug resistance protein 5 (ABCC5) confers resistance to 5-fluorouracil and transports its monophosphorylated metabolites Mol. Cancer Ther. 2005, 4 (5) 855-63 (Pubitemid 40767130)
115. Oguri, T.; Achiwa, H.; Sato, S.; Bessho, Y.; Takano, Y.; Miyazaki, M.; Muramatsu, H.; Maeda, H.; Niimi, T.; Ueda, R. The determinants of sensitivity and acquired resistance to gemcitabine differ in non-small cell lung cancer: a role of ABCC5 in gemcitabine sensitivity Mol. Cancer Ther. 2006, 5 (7) 1800-6 (Pubitemid 44323248)
116. Guo, Y.; Kotova, E.; Chen, Z. S.; Lee, K.; Hopper-Borge, E.; Belinsky, M. G.; Kruh, G. D. MRP8, ATP-binding cassette C11 (ABCC11), is a cyclic nucleotide efflux pump and a resistance factor for fluoropyrimidines 2′,3′- dideoxycytidine and 9′-(2′-phosphonylmethoxyethyl)adenine J. Biol. Chem. 2003, 278 (32) 29509-14 (Pubitemid 36962331)
117. Hopper-Borge, E.; Xu, X.; Shen, T.; Shi, Z.; Chen, Z. S.; Kruh, G. D. Human multidrug resistance protein 7 (ABCC10) is a resistance factor for nucleoside analogues and epothilone B Cancer Res. 2009, 69 (1) 178-84
118. Bessho, Y.; Oguri, T.; Ozasa, H.; Uemura, T.; Sakamoto, H.; Miyazaki, M.; Maeno, K.; Sato, S.; Ueda, R. ABCC10/MRP7 is associated with vinorelbine resistance in non-small cell lung cancer Oncol. Rep. 2009, 21 (1) 263-8
119. Chen, K. G.; Valencia, J. C.; Lai, B.; Zhang, G.; Paterson, J. K.; Rouzaud, F.; Berens, W.; Wincovitch, S. M.; Garfield, S. H.; Leapman, R. D.; Hearing, V. J.; Gottesman, M. M. Melanosomal sequestration of cytotoxic drugs contributes to the intractability of malignant melanomas Proc. Natl. Acad. Sci. U.S.A. 2006, 103 (26) 9903-7 (Pubitemid 43993595)
120. Chen, K. G.; Szakacs, G.; Annereau, J. P.; Rouzaud, F.; Liang, X. J.; Valencia, J. C.; Nagineni, C. N.; Hooks, J. J.; Hearing, V. J.; Gottesman, M. M. Principal expression of two mRNA isoforms (ABCB 5alpha and ABCB 5beta) of the ATP-binding cassette transporter gene ABCB 5 in melanoma cells and melanocytes Pigm. Cell Res. 2005, 18 (2) 102-12 (Pubitemid 40445046)
121. Steinbach, D.; Gillet, J. P.; Sauerbrey, A.; Gruhn, B.; Dawczynski, K.; Bertholet, V.; de Longueville, F.; Zintl, F.; Remacle, J.; Efferth, T. ABCA3 as a possible cause of drug resistance in childhood acute myeloid leukemia Clin. Cancer Res. 2006, 12 (14 Part 1) 4357-63
122. Cheong, N.; Madesh, M.; Gonzales, L. W.; Zhao, M.; Yu, K.; Ballard, P. L.; Shuman, H. Functional and trafficking defects in ATP binding cassette A3 mutants associated with respiratory distress syndrome J. Biol. Chem. 2006, 281 (14) 9791-800 (Pubitemid 43864698)
123. Frank, N. Y.; Pendse, S. S.; Lapchak, P. H.; Margaryan, A.; Shlain, D.; Doeing, C.; Sayegh, M. H.; Frank, M. H. Regulation of progenitor cell fusion by ABCB5 P-glycoprotein, a novel human ATP-binding cassette transporter J. Biol. Chem. 2003, 278 (47) 47156-65 (Pubitemid 37452302)
124. Schatton, T.; Murphy, G. F.; Frank, N. Y.; Yamaura, K.; Waaga-Gasser, A. M.; Gasser, M.; Zhan, Q.; Jordan, S.; Duncan, L. M.; Weishaupt, C.; Fuhlbrigge, R. C.; Kupper, T. S.; Sayegh, M. H.; Frank, M. H. Identification of cells initiating human melanomas Nature 2008, 451 (7176) 345-9
125. Wulf, G. G.; Modlich, S.; Inagaki, N.; Reinhardt, D.; Schroers, R.; Griesinger, F.; Trumper, L. ABC transporter ABCA3 is expressed in acute myeloid leukemia blast cells and participates in vesicular transport Haematologica 2004, 89 (11) 1395-7 (Pubitemid 39540580)
126. Chapuy, B.; Panse, M.; Radunski, U.; Koch, R.; Wenzel, D.; Inagaki, N.; Haase, D.; Truemper, L.; Wulf, G. G. ABC transporter A3 facilitates lysosomal sequestration of imatinib and modulates susceptibility of chronic myeloid leukemia cell lines to this drug Haematologica 2009, 94 (11) 1528-36
127. Dobson, P. D.; Kell, D. B. Carrier-mediated cellular uptake of pharmaceutical drugs: an exception or the rule? Nat. Rev. 2008, 7 (3) 205-20 (Pubitemid 351321232)
128. Hediger, M. A.; Romero, M. F.; Peng, J. B.; Rolfs, A.; Takanaga, H.; Bruford, E. A. The ABCs of solute carriers: physiological, pathological and therapeutic implications of human membrane transport proteinsIntroduction Pfluegers Arch. 2004, 447 (5) 465-8 (Pubitemid 38241432)
129. Hall, M. D.; Okabe, M.; Shen, D. W.; Liang, X. J.; Gottesman, M. M. The
130. Okabe, M.; Szakacs, G.; Reimers, M. A.; Suzuki, T.; Hall, M. D.; Abe, T.; Weinstein, J. N.; Gottesman, M. M. Profiling SLCO and SLC22 genes in the NCI-60 cancer cell lines to identify drug uptake transporters Mol. Cancer Ther. 2008, 7 (9) 3081-91
131. Smith, N. F.; Acharya, M. R.; Desai, N.; Figg, W. D.; Sparreboom, A. Identification of OATP1B3 as a high-affinity hepatocellular transporter of paclitaxel Cancer Biol. Ther. 2005, 4 (8) 815-8
132. Assaraf, Y. G. Molecular basis of antifolate resistance Cancer Metastasis Rev. 2007, 26 (1) 153-81 (Pubitemid 46452189)
133. Gately, D. P.; Howell, S. B. Cellular accumulation of the anticancer agent cisplatin: a review Br. J. Cancer 1993, 67 (6) 1171-6 (Pubitemid 23172848)
134. Shen, D. W.; Akiyama, S.; Schoenlein, P.; Pastan, I.; Gottesman, M. M. Characterisation of high-level cisplatin-resistant cell lines established from a human hepatoma cell line and human KB adenocarcinoma cells: cross-resistance and protein changes Br. J. Cancer 1995, 71 (4) 676-83
135. Shen, D.; Pastan, I.; Gottesman, M. M. Cross-resistance to methotrexate and metals in human cisplatin-resistant cell lines results from a pleiotropic defect in accumulation of these compounds associated with reduced plasma membrane binding proteins Cancer Res. 1998, 58 (2) 268-75 (Pubitemid 28047066)
136. Shen, D. W.; Goldenberg, S.; Pastan, I.; Gottesman, M. M. Decreased accumulation of [14C]carboplatin in human cisplatin-resistant cells results from reduced energy-dependent uptake J. Cell. Physiol. 2000, 183 (1) 108-16 (Pubitemid 30130231)
137. Kuo, M. T.; Chen, H. H.; Song, I. S.; Savaraj, N.; Ishikawa, T. The roles of copper transporters in cisplatin resistance Cancer Metastasis Rev. 2007, 26 (1) 71-83 (Pubitemid 46452185)
138. Awasthi, S.; Singhal, S. S.; Awasthi, Y. C.; Martin, B.; Woo, J. H.; Cunningham, C. C.; Frankel, A. E. RLIP76 and Cancer Clin. Cancer Res. 2008, 14 (14) 4372-7
139. Singhal, S. S.; Singhal, J.; Nair, M. P.; Lacko, A. G.; Awasthi, Y. C.; Awasthi, S. Doxorubicin transport by RALBP1 and ABCG2 in lung and breast cancer Int. J. Oncol. 2007, 30 (3) 717-25
140. Drake, K. J.; Singhal, J.; Yadav, S.; Nadkar, A.; Pungaliya, C.; Singhal, S. S.; Awasthi, S. RALBP1/RLIP76 mediates multidrug resistance Int. J. Oncol. 2007, 30 (1) 139-44
141. Mbeunkui, F.; Johann, D. J., Jr. Cancer and the tumor microenvironment: a review of an essential relationship Cancer Chemother. Pharmacol. 2009, 63 (4) 571-82
142. Sausville, E. A. The challenge of pathway and environment-mediated drug resistance Cancer Metastasis Rev. 2001, 20 (1-2) 117-22 (Pubitemid 34074687)
143. Meads, M. B.; Gatenby, R. A.; Dalton, W. S. Environment-mediated drug resistance: a major contributor to minimal residual disease Nat. Rev. Cancer 2009, 9 (9) 665-74
144. Lehne, G.; De Angelis, P.; den Boer, M.; Rugstad, H. E. Growth inhibition, cytokinesis failure and apoptosis of multidrug-resistant leukemia cells after treatment with P-glycoprotein inhibitory agents Leukemia 1999, 13 (5) 768-78 (Pubitemid 29243629)
145. Lehne, G.; Sorensen, D. R.; Tjonnfjord, G. E.; Beiske, C.; Hagve, T. A.; Rugstad, H. E.; Clausen, O. P. The cyclosporin PSC 833 increases survival and delays engraftment of human multidrug-resistant leukemia cells in xenotransplanted NOD-SCID mice Leukemia 2002, 16 (12) 2388-94 (Pubitemid 36054372)
146. Peaston, A. E.; Gardaneh, M.; Franco, A. V.; Hocker, J. E.; Murphy, K. M.; Farnsworth, M. L.; Catchpoole, D. R.; Haber, M.; Norris, M. D.; Lock, R. B.; Marshall, G. M. MRP1 gene expression level regulates the death and differentiation response of neuroblastoma cells Br. J. Cancer 2001, 85 (10) 1564-71 (Pubitemid 34001591)
147. Kuss, B. J.; Corbo, M.; Lau, W. M.; Fennell, D. A.; Dean, N. M.; Cotter, F. E. In vitro and in vivo downregulation of MRP1 by antisense oligonucleotides: a potential role in neuroblastoma therapy Int. J. Cancer 2002, 98 (1) 128-33 (Pubitemid 34113429)
148. Sassi, Y.; Lipskaia, L.; Vandecasteele, G.; Nikolaev, V. O.; Hatem, S. N.; Cohen Aubart, F.; Russel, F. G.; Mougenot, N.; Vrignaud, C.; Lechat, P.; Lompre, A. M.; Hulot, J. S. Multidrug resistance-associated protein 4 regulates cAMP-dependent signaling pathways and controls human and rat SMC proliferation J. Clin. Invest. 2008, 118 (8) 2747-57
149. Bhattacharya, S.; Das, A.; Mallya, K.; Ahmad, I. Maintenance of retinal stem cells by Abcg2 is regulated by notch signaling J. Cell Sci. 2007, 120 (Part 15) 2652-62 (Pubitemid 47323873)
150. Al-Bataineh, M. M.; van der Merwe, D.; Schultz, B. D.; Gehring, R. Tumor necrosis factor alpha increases P-glycoprotein expression in a BME-UV in vitro model of mammary epithelial cells Biopharm. Drug Dispos. 2010, 31 (8-9) 506-15
151. Evseenko, D. A.; Paxton, J. W.; Keelan, J. A. Independent regulation of apical and basolateral drug transporter expression and function in placental trophoblasts by cytokines, steroids, and growth factors Drug Metabolism Dispos. 2007, 35 (4) 595-601 (Pubitemid 46513262)
152. Heemskerk, S.; Peters, J. G.; Louisse, J.; Sagar, S.; Russel, F. G.; Masereeuw, R. Regulation of P-glycoprotein in renal proximal tubule epithelial cells by LPS and TNF-alpha J. Biomed. Biotechnol. 2010, 2010, 525180
153. Hawkins, B. T.; Sykes, D. B.; Miller, D. S. Rapid, reversible modulation of blood-brain barrier P-glycoprotein transport activity by vascular endothelial growth factor J. Neurosci. 2010, 30 (4) 1417-25
154. Ho, E. A.; Piquette-Miller, M. Regulation of multidrug resistance by pro-inflammatory cytokines Curr. Cancer Drug Targets 2006, 6 (4) 295-311 (Pubitemid 43961865)
155. Frederiksen, L. J.; Siemens, D. R.; Heaton, J. P.; Maxwell, L. R.; Adams, M. A.; Graham, C. H. Hypoxia induced resistance to doxorubicin in prostate cancer cells is inhibited by low concentrations of glyceryl trinitrate J. Urol. 2003, 170 (3) 1003-7 (Pubitemid 36999621)
156. Teicher, B. A. Hypoxia and drug resistance Cancer Metastasis Rev. 1994, 13 (2) 139-68 (Pubitemid 24220002)
157. Wartenberg, M.; Ling, F. C.; Muschen, M.; Klein, F.; Acker, H.; Gassmann, M.; Petrat, K.; Putz, V.; Hescheler, J.; Sauer, H. Regulation of the multidrug resistance transporter P-glycoprotein in multicellular tumor spheroids by hypoxia-inducible factor (HIF-1) and reactive oxygen species FASEB J. 2003, 17 (3) 503-5
158. Comerford, K. M.; Wallace, T. J.; Karhausen, J.; Louis, N. A.; Montalto, M. C.; Colgan, S. P. Hypoxia-inducible factor-1-dependent regulation of the multidrug resistance (MDR1) gene Cancer Res. 2002, 62 (12) 3387-94 (Pubitemid 34651384)
159. Hamanaka, R. B.; Chandel, N. S. Mitochondrial reactive oxygen species regulate hypoxic signaling Curr. Opin. Cell Biol. 2009, 21 (6) 894-9
160. Griguer, C. E.; Oliva, C. R.; Kelley, E. E.; Giles, G. I.; Lancaster, J. R., Jr.; Gillespie, G. Y. Xanthine oxidase-dependent regulation of hypoxia-inducible factor in cancer cells Cancer Res. 2006, 66 (4) 2257-63
161. Abramov, A. Y.; Scorziello, A.; Duchen, M. R. Three distinct mechanisms generate oxygen free radicals in neurons and contribute to cell death during anoxia and reoxygenation J. Neurosci. 2007, 27 (5) 1129-38 (Pubitemid 46203321)
162. Chandel, N. S.; Maltepe, E.; Goldwasser, E.; Mathieu, C. E.; Simon, M. C.; Schumacker, P. T. Mitochondrial reactive oxygen species trigger hypoxia-induced transcription Proc. Natl. Acad. Sci. U.S.A. 1998, 95 (20) 11715-20 (Pubitemid 28460480)
163. Chandel, N. S.; McClintock, D. S.; Feliciano, C. E.; Wood, T. M.; Melendez, J. A.; Rodriguez, A. M.; Schumacker, P. T. Reactive oxygen species generated at mitochondrial complex III stabilize hypoxia-inducible factor-1alpha during hypoxia: a mechanism of O2 sensing J. Biol. Chem. 2000, 275 (33) 25130-8
164. Yuan, G.; Adhikary, G.; McCormick, A. A.; Holcroft, J. J.; Kumar, G. K.; Prabhakar, N. R. Role of oxidative stress in intermittent hypoxia-induced immediate early gene activation in rat PC12 cells J. Physiol. 2004, 557 (Part 3) 773-83 (Pubitemid 38961615)
165. Gloire, G.; Legrand-Poels, S.; Piette, J. NF-kappaB activation by reactive oxygen species: fifteen years later Biochem. Pharmacol. 2006, 72 (11) 1493-505 (Pubitemid 44666727)
166. Ziemann, C.; Burkle, A.; Kahl, G. F.; Hirsch-Ernst, K. I. Reactive oxygen species participate in mdr1b mRNA and P-glycoprotein overexpression in primary rat hepatocyte cultures Carcinogenesis 1999, 20 (3) 407-14 (Pubitemid 29112627)
167. Felix, R. A.; Barrand, M. A. P-glycoprotein expression in rat brain endothelial cells: evidence for regulation by transient oxidative stress J. Neurochem. 2002, 80 (1) 64-72 (Pubitemid 34614578)
168. Deng, L.; Lin-Lee, Y. C.; Claret, F. X.; Kuo, M. T. 2-acetylaminofluorene up-regulates rat mdr1b expression through generating reactive oxygen species that activate NF-kappa B pathway J. Biol. Chem. 2001, 276 (1) 413-20 (Pubitemid 32050334)
169. Wartenberg, M.; Ling, F. C.; Schallenberg, M.; Baumer, A. T.; Petrat, K.; Hescheler, J.; Sauer, H. Down-regulation of intrinsic P-glycoprotein expression in multicellular prostate tumor spheroids by reactive oxygen species J. Biol. Chem. 2001, 276 (20) 17420-8
170. Lotz, C.; Kelleher, D. K.; Gassner, B.; Gekle, M.; Vaupel, P.; Thews, O. Role of the tumor microenvironment in the activity and expression of the p-glycoprotein in human colon carcinoma cells Oncol. Rep. 2007, 17 (1) 239-44
171. Thews, O.; Gassner, B.; Kelleher, D. K.; Schwerdt, G.; Gekle, M. Impact of extracellular acidity on the activity of P-glycoprotein and the cytotoxicity of chemotherapeutic drugs Neoplasia 2006, 8 (2) 143-52
172. Dean, M.; Fojo, T.; Bates, S. Tumour stem cells and drug resistance Nat. Rev. Cancer 2005, 5 (4) 275-84 (Pubitemid 40488633)
173. Seidel, S.; Garvalov, B. K.; Wirta, V.; von Stechow, L.; Schanzer, A.; Meletis, K.; Wolter, M.; Sommerlad, D.; Henze, A. T.; Nister, M.; Reifenberger, G.; Lundeberg, J.; Frisen, J.; Acker, T. A hypoxic niche regulates glioblastoma stem cells through hypoxia inducible factor 2 alpha Brain 2010, 133 (Part 4) 983-95
174. Axelson, H.; Fredlund, E.; Ovenberger, M.; Landberg, G.; Pahlman, S. Hypoxia-induced dedifferentiation of tumor cells - a mechanism behind heterogeneity and aggressiveness of solid tumors Semin. Cell Dev. Biol. 2005, 16 (4-5) 554-63 (Pubitemid 41247879)
175. Heddleston, J. M.; Li, Z.; Lathia, J. D.; Bao, S.; Hjelmeland, A. B.; Rich, J. N. Hypoxia inducible factors in cancer stem cells Br. J. Cancer 2010, 102 (5) 789-95
176. Keith, B.; Simon, M. C. Hypoxia-inducible factors, stem cells, and cancer Cell 2007, 129 (3) 465-72 (Pubitemid 46660978)
177. Mazumdar, J.; Dondeti, V.; Simon, M. C. Hypoxia-inducible factors in stem cells and cancer J. Cell. Mol. Med. 2009, 13 (11-12) 4319-28
178. Angelastro, J. M.; Lame, M. W. Overexpression of CD133 promotes drug resistance in C6 glioma cells Mol. Cancer Res. 2010, 8 (8) 1105-15
179. Wang, X. Q.; Ongkeko, W. M.; Chen, L.; Yang, Z. F.; Lu, P.; Chen, K. K.; Lopez, J. P.; Poon, R. T.; Fan, S. T. Octamer 4 (Oct4) mediates chemotherapeutic drug resistance in liver cancer cells through a potential Oct4-AKT-ATP-binding cassette G2 pathway Hepatology 2010, 52 (2) 528-39
180. Wu, C. P.; Calcagno, A. M.; Ambudkar, S. V. Reversal of ABC drug transporter-mediated multidrug resistance in cancer cells: evaluation of current strategies Curr. Mol. Pharmacol. 2008, 1 (2) 93-105
181. Wu, C. P.; Ohnuma, S.; Ambudkar, S. V. Discovering Natural Product Modulators to Overcome Multidrug Resistance in Cancer Chemotherapy. Curr. Pharm. Biotechnol. 2011.
182. Hall, M. D.; Handley, M. D.; Gottesman, M. M. Is resistance useless? Multidrug resistance and collateral sensitivity Trends Pharmacol. Sci. 2009, 30 (10) 546-56
183. Kessel, D.; Botterill, V.; Wodinsky, I. Uptake and retention of daunomycin by mouse leukemic cells as factors in drug response Cancer Res. 1968, 28 (5) 938-41
184. Ling, V.; Thompson, L. H. Reduced permeability in CHO cells as a mechanism of resistance to colchicine J. Cell. Physiol. 1974, 83 (1) 103-16
185. See, Y. P.; Carlsen, S. A.; Till, J. E.; Ling, V. Increased drug permeability in Chinese hamster ovary cells in the presence of cyanide Biochim. Biophys. Acta 1974, 373 (2) 242-52
186. Ling, V. Drug resistance and membrane alteration in mutants of mammalian cells Can. J. Genet. Cytol. 1975, 17 (4) 503-15
187. Ling, V.; Baker, R. M. Dominance of colchicine resistance in hybrid CHO cells Somatic Cell Genet. 1978, 4 (2) 193-200 (Pubitemid 8327195)
188. Debenham, P. G.; Kartner, N.; Siminovitch, L.; Riordan, J. R.; Ling, V. DNA-mediated transfer of multiple drug resistance and plasma membrane glycoprotein expression Mol. Cell. Biol. 1982, 2 (8) 881-9 (Pubitemid 12028244)
189. Kartner, N.; Riordan, J. R.; Ling, V. Cell surface P-glycoprotein associated with multidrug resistance in mammalian cell lines Science (New York, N.Y.) 1983, 221 (4617) 1285-8 (Pubitemid 13005502)
190. Roninson, I. B.; Abelson, H. T.; Housman, D. E.; Howell, N.; Varshavsky, A. Amplification of specific DNA sequences correlates with multi-drug resistance in Chinese hamster cells Nature 1984, 309 (5969) 626-8 (Pubitemid 14106442)
191. Kartner, N.; Evernden-Porelle, D.; Bradley, G.; Ling, V. Detection of P-glycoprotein in multidrug-resistant cell lines by monoclonal antibodies Nature 1985, 316 (6031) 820-3 (Pubitemid 15003741)
192. Higgins, C. F.; Hiles, I. D.; Whalley, K.; Jamieson, D. J. Nucleotide binding by membrane components of bacterial periplasmic binding protein-dependent transport systems EMBO J. 1985, 4 (4) 1033-9
193. Gros, P.; Croop, J.; Roninson, I.; Varshavsky, A.; Housman, D. E. Isolation and characterization of DNA sequences amplified in multidrug-resistant hamster cells Proc. Natl. Acad. Sci. U.S.A. 1986, 83 (2) 337-41 (Pubitemid 16080008)
194. Gros, P.; Croop, J.; Housman, D. Mammalian multidrug resistance gene: complete cDNA sequence indicates strong homology to bacterial transport proteins Cell 1986, 47 (3) 371-80 (Pubitemid 17210151)
195. Chen, C. J.; Chin, J. E.; Ueda, K.; Clark, D. P.; Pastan, I.; Gottesman, M. M.; Roninson, I. B. Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cells Cell 1986, 47 (3) 381-9 (Pubitemid 17210152)
196. Gros, P.; Ben Neriah, Y. B.; Croop, J. M.; Housman, D. E. Isolation and expression of a complementary DNA that confers multidrug resistance Nature 1986, 323 (6090) 728-31 (Pubitemid 17172974)
197. Ueda, K.; Pastan, I.; Gottesman, M. M. Isolation and sequence of the promoter region of the human multidrug-resistance (P-glycoprotein) gene J. Biol. Chem. 1987, 262 (36) 17432-6 (Pubitemid 18032220)
198. Choi, K. H.; Chen, C. J.; Kriegler, M.; Roninson, I. B. An altered pattern of cross-resistance in multidrug-resistant human cells results from spontaneous mutations in the mdr1 (P-glycoprotein) gene Cell 1988, 53 (4) 519-29
199. Pastan, I.; Gottesman, M. M.; Ueda, K.; Lovelace, E.; Rutherford, A. V.; Willingham, M. C. A retrovirus carrying an MDR1 cDNA confers multidrug resistance and polarized expression of P-glycoprotein in MDCK cells Proc. Natl. Acad. Sci. U.S.A. 1988, 85 (12) 4486-90
200. Cordon-Cardo, C.; O'Brien, J. P.; Casals, D.; Rittman-Grauer, L.; Biedler, J. L.; Melamed, M. R.; Bertino, J. R. Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites Proc. Natl. Acad. Sci. U.S.A. 1989, 86 (2) 695-8 (Pubitemid 19037807)
201. Jones, T. R.; Zamboni, R.; Belley, M.; Champion, E.; Charette, L.; Ford-Hutchinson, A. W.; Frenette, R.; Gauthier, J. Y.; Leger, S.; Masson, P. Pharmacology of L-660,711 (MK-571): a novel potent and selective leukotriene D4 receptor antagonist Can. J. Physiol. Pharmacol. 1989, 67 (1) 17-28 (Pubitemid 19068107)
202. Noonan, K. E.; Beck, C.; Holzmayer, T. A.; Chin, J. E.; Wunder, J. S.; Andrulis, I. L.; Gazdar, A. F.; Willman, C. L.; Griffith, B.; Von Hoff, D. D. Quantitative analysis of MDR1 (multidrug resistance) gene expression in human tumors by polymerase chain reaction Proc. Natl. Acad. Sci. U.S.A. 1990, 87 (18) 7160-4
203. Raviv, Y.; Pollard, H. B.; Bruggemann, E. P.; Pastan, I.; Gottesman, M. M. Photosensitized labeling of a functional multidrug transporter in living drug-resistant tumor cells J. Biol. Chem. 1990, 265 (7) 3975-80
204. Chan, H. S.; Haddad, G.; Thorner, P. S.; DeBoer, G.; Lin, Y. P.; Ondrusek, N.; Yeger, H.; Ling, V. P-glycoprotein expression as a predictor of the outcome of therapy for neuroblastoma N. Engl. J. Med. 1991, 325 (23) 1608-14
205. Taylor, C. W.; Dalton, W. S.; Parrish, P. R.; Gleason, M. C.; Bellamy, W. T.; Thompson, F. H.; Roe, D. J.; Trent, J. M. Different mechanisms of decreased drug accumulation in doxorubicin and mitoxantrone resistant variants of the MCF7 human breast cancer cell line Br. J. Cancer 1991, 63 (6) 923-9
206. Chaudhary, P. M.; Roninson, I. B. Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoietic stem cells Cell 1991, 66 (1) 85-94 (Pubitemid 121001349)
207. Sorrentino, B. P.; Brandt, S. J.; Bodine, D.; Gottesman, M.; Pastan, I.; Cline, A.; Nienhuis, A. W. Selection of drug-resistant bone marrow cells in vivo after retroviral transfer of human MDR1 Science (New York, N.Y.) 1992, 257 (5066) 99-103
208. Chaudhary, P. M.; Roninson, I. B. Induction of multidrug resistance in human cells by transient exposure to different chemotherapeutic drugs J. Natl. Cancer Inst. 1993, 85 (8) 632-9 (Pubitemid 23120508)
209. Hipfner, D. R.; Gauldie, S. D.; Deeley, R. G.; Cole, S. P. Detection of the M(r) 190,000 multidrug resistance protein, MRP, with monoclonal antibodies Cancer Res. 1994, 54 (22) 5788-92
210. Schinkel, A. H.; Mayer, U.; Wagenaar, E.; Mol, C. A.; van Deemter, L.; Smit, J. J.; van der Valk, M. A.; Voordouw, A. C.; Spits, H.; van Tellingen, O.; Zijlmans, J. M.; Fibbe, W. E.; Borst, P. Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins Proc. Natl. Acad. Sci. U.S.A. 1997, 94 (8) 4028-33 (Pubitemid 27180493)
211. Smyth, M. J.; Krasovskis, E.; Sutton, V. R.; Johnstone, R. W. The drug efflux protein, P-glycoprotein, additionally protects drug-resistant tumor cells from multiple forms of caspase-dependent apoptosis Proc. Natl. Acad. Sci. U.S.A. 1998, 95 (12) 7024-9
212. Wijnholds, J.; Scheffer, G. L.; van der Valk, M.; van der Valk, P.; Beijnen, J. H.; Scheper, R. J.; Borst, P. Multidrug resistance protein 1 protects the oropharyngeal mucosal layer and the testicular tubules against drug-induced damage J. Exp. Med. 1998, 188 (5) 797-808 (Pubitemid 28433407)
213. Lazarowski, A.; Sevlever, G.; Taratuto, A.; Massaro, M.; Rabinowicz, A. Tuberous sclerosis associated with MDR1 gene expression and drug-resistant epilepsy Pediatr. Neurol. 1999, 21 (4) 731-4 (Pubitemid 29505340)
214. Miyake, K.; Mickley, L.; Litman, T.; Zhan, Z.; Robey, R.; Cristensen, B.; Brangi, M.; Greenberger, L.; Dean, M.; Fojo, T.; Bates, S. E. Molecular cloning of cDNAs which are highly overexpressed in mitoxantrone-resistant cells: demonstration of homology to ABC transport genes Cancer Res. 1999, 59 (1) 8-13 (Pubitemid 29062946)
215. Sauna, Z. E.; Ambudkar, S. V. Evidence for a requirement for ATP hydrolysis at two distinct steps during a single turnover of the catalytic cycle of human P-glycoprotein Proc. Natl. Acad. Sci. U.S.A. 2000, 97 (6) 2515-20 (Pubitemid 30159202)
216. Jonker, J. W.; Smit, J. W.; Brinkhuis, R. F.; Maliepaard, M.; Beijnen, J. H.; Schellens, J. H.; Schinkel, A. H. Role of breast cancer resistance protein in the bioavailability and fetal penetration of topotecan J. Natl. Cancer Inst. 2000, 92 (20) 1651-6
217. Rabindran, S. K.; Ross, D. D.; Doyle, L. A.; Yang, W.; Greenberger, L. M. Fumitremorgin C reverses multidrug resistance in cells transfected with the breast cancer resistance protein Cancer Res. 2000, 60 (1) 47-50 (Pubitemid 30058728)
218. Conrad, S.; Kauffmann, H. M.; Ito, K.; Deeley, R. G.; Cole, S. P.; Schrenk, D. Identification of human multidrug resistance protein 1 (MRP1) mutations and characterization of a G671V substitution J. Hum. Genet. 2001, 46 (11) 656-63 (Pubitemid 33134743)
219. Schultz, M. J.; Wijnholds, J.; Peppelenbosch, M. P.; Vervoordeldonk, M. J.; Speelman, P.; van Deventer, S. J.; Borst, P.; van der Poll, T. Mice lacking the multidrug resistance protein 1 are resistant to Streptococcus pneumoniae-induced pneumonia J. Immunol. 2001, 166 (6) 4059-64 (Pubitemid 32224936)
220. Honjo, Y.; Hrycyna, C. A.; Yan, Q. W.; Medina-Perez, W. Y.; Robey, R. W.; van de Laar, A.; Litman, T.; Dean, M.; Bates, S. E. Acquired mutations in the MXR/BCRP/ABCP gene alter substrate specificity in MXR/BCRP/ABCP-overexpressing cells Cancer Res. 2001, 61 (18) 6635-9 (Pubitemid 32896477)
221. Maliepaard, M.; Scheffer, G. L.; Faneyte, I. F.; van Gastelen, M. A.; Pijnenborg, A. C.; Schinkel, A. H.; van De Vijver, M. J.; Scheper, R. J.; Schellens, J. H. Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues Cancer Res. 2001, 61 (8) 3458-64 (Pubitemid 32695041)
222. Kage, K.; Tsukahara, S.; Sugiyama, T.; Asada, S.; Ishikawa, E.; Tsuruo, T.; Sugimoto, Y. Dominant-negative inhibition of breast cancer resistance protein as drug efflux pump through the inhibition of S-S dependent homodimerization Int. J. Cancer 2002, 97 (5) 626-30 (Pubitemid 34087801)
223. Allen, J. D.; Jackson, S. C.; Schinkel, A. H. A mutation hot spot in the Bcrp1 (Abcg2) multidrug transporter in mouse cell lines selected for Doxorubicin resistance Cancer Res. 2002, 62 (8) 2294-9 (Pubitemid 34411707)
224. Zhou, S.; Morris, J. J.; Barnes, Y.; Lan, L.; Schuetz, J. D.; Sorrentino, B. P. Bcrp1 gene expression is required for normal numbers of side population stem cells in mice, and confers relative protection to mitoxantrone in hematopoietic cells in vivo Proc. Natl. Acad. Sci. U.S.A. 2002, 99 (19) 12339-44
225. Kim, M.; Turnquist, H.; Jackson, J.; Sgagias, M.; Yan, Y.; Gong, M.; Dean, M.; Sharp, J. G.; Cowan, K. The multidrug resistance transporter ABCG2 (breast cancer resistance protein 1) effluxes Hoechst 33342 and is overexpressed in hematopoietic stem cells Clin. Cancer Res. 2002, 8 (1) 22-8 (Pubitemid 34101455)
226. Jonker, J. W.; Buitelaar, M.; Wagenaar, E.; Van Der Valk, M. A.; Scheffer, G. L.; Scheper, R. J.; Plosch, T.; Kuipers, F.; Elferink, R. P.; Rosing, H.; Beijnen, J. H.; Schinkel, A. H. The breast cancer resistance protein protects against a major chlorophyll-derived dietary phototoxin and protoporphyria Proc. Natl. Acad. Sci. U.S.A. 2002, 99 (24) 15649-54 (Pubitemid 35403986)
227. Cooray, H. C.; Blackmore, C. G.; Maskell, L.; Barrand, M. A. Localisation of breast cancer resistance protein in microvessel endothelium of human brain NeuroReport 2002, 13 (16) 2059-63 (Pubitemid 36005925)
228. Litman, T.; Jensen, U.; Hansen, A.; Covitz, K. M.; Zhan, Z.; Fetsch, P.; Abati, A.; Hansen, P. R.; Horn, T.; Skovsgaard, T.; Bates, S. E. Use of peptide antibodies to probe for the mitoxantrone resistance-associated protein MXR/BCRP/ABCP/ABCG2 Biochim. Biophys. Acta 2002, 1565 (1) 6-16 (Pubitemid 35239827)
229. Nakanishi, T.; Karp, J. E.; Tan, M.; Doyle, L. A.; Peters, T.; Yang, W.; Wei, D.; Ross, D. D. Quantitative analysis of breast cancer resistance protein and cellular resistance to flavopiridol in acute leukemia patients Clin. Cancer Res. 2003, 9 (9) 3320-8 (Pubitemid 37082726)
230. Ee, P. L.; Kamalakaran, S.; Tonetti, D.; He, X.; Ross, D. D.; Beck, W. T. Identification of a novel estrogen response element in the breast cancer resistance protein (ABCG2) gene Cancer Res. 2004, 64 (4) 1247-51 (Pubitemid 38235590)
231. Xu, J.; Liu, Y.; Yang, Y.; Bates, S.; Zhang, J. T. Characterization of oligomeric human half-ABC transporter ATP-binding cassette G2 J. Biol. Chem. 2004, 279 (19) 19781-9 (Pubitemid 38623417)
232. Ifergan, I.; Shafran, A.; Jansen, G.; Hooijberg, J. H.; Scheffer, G. L.; Assaraf, Y. G. Folate deprivation results in the loss of breast cancer resistance protein (BCRP/ABCG2) expression. A role for BCRP in cellular folate homeostasis J. Biol. Chem. 2004, 279 (24) 25527-34 (Pubitemid 38756812)
233. Krishnamurthy, P.; Ross, D. D.; Nakanishi, T.; Bailey-Dell, K.; Zhou, S.; Mercer, K. E.; Sarkadi, B.; Sorrentino, B. P.; Schuetz, J. D. The stem cell marker Bcrp/ABCG2 enhances hypoxic cell survival through interactions with heme J. Biol. Chem. 2004, 279 (23) 24218-25 (Pubitemid 38725283)
234. Szakacs, G.; Annereau, J. P.; Lababidi, S.; Shankavaram, U.; Arciello, A.; Bussey, K. J.; Reinhold, W.; Guo, Y.; Kruh, G. D.; Reimers, M.; Weinstein, J. N.; Gottesman, M. M. Predicting drug sensitivity and resistance: profiling ABC transporter genes in cancer cells Cancer Cell 2004, 6 (2) 129-37 (Pubitemid 39485685)
235. Trompier, D.; Chang, X. B.; Barattin, R.; du Moulinet D'Hardemare, A.; Di Pietro, A.; Baubichon-Cortay, H. Verapamil and its derivative trigger apoptosis through glutathione extrusion by multidrug resistance protein MRP1 Cancer Res. 2004, 64 (14) 4950-6 (Pubitemid 38924542)
236. Breedveld, P.; Pluim, D.; Cipriani, G.; Wielinga, P.; van Tellingen, O.; Schinkel, A. H.; Schellens, J. H. The effect of Bcrp1 (Abcg2) on the in vivo pharmacokinetics and brain penetration of imatinib mesylate (Gleevec): implications for the use of breast cancer resistance protein and P-glycoprotein inhibitors to enable the brain penetration of imatinib in patients Cancer Res. 2005, 65 (7) 2577-82 (Pubitemid 40490054)
237. Zhou, S.; Zong, Y.; Ney, P. A.; Nair, G.; Stewart, C. F.; Sorrentino, B. P. Increased expression of the Abcg2 transporter during erythroid maturation plays a role in decreasing cellular protoporphyrin IX levels Blood 2005, 105 (6) 2571-6 (Pubitemid 40387061)
238. Janvilisri, T.; Shahi, S.; Venter, H.; Balakrishnan, L.; van Veen, H. W. Arginine-482 is not essential for transport of antibiotics, primary bile acids and unconjugated sterols by the human breast cancer resistance protein (ABCG2) Biochem. J. 2005, 385 (Part 2) 419-26 (Pubitemid 40165074)
239. Watts, R. N.; Hawkins, C.; Ponka, P.; Richardson, D. R. Nitrogen monoxide (NO)-mediated iron release from cells is linked to NO-induced glutathione efflux via multidrug resistance-associated protein 1 Proc. Natl. Acad. Sci. U.S.A. 2006, 103 (20) 7670-5
240. Mitra, P.; Oskeritzian, C. A.; Payne, S. G.; Beaven, M. A.; Milstien, S.; Spiegel, S. Role of ABCC1 in export of sphingosine-1-phosphate from mast cells Proc. Natl. Acad. Sci. U.S.A. 2006, 103 (44) 16394-9 (Pubitemid 44715207)
241. Kimchi-Sarfaty, C.; Oh, J. M.; Kim, I. W.; Sauna, Z. E.; Calcagno, A. M.; Ambudkar, S. V.; Gottesman, M. M. A "silent" polymorphism in the MDR1 gene changes substrate specificity Science (New York, N.Y.) 2007, 315 (5811) 525-8 (Pubitemid 46175758)
242. Shukla, S.; Wu, C. P.; Nandigama, K.; Ambudkar, S. V. The naphthoquinones, vitamin K3 and its structural analogue plumbagin, are substrates of the multidrug resistance linked ATP binding cassette drug transporter ABCG2 Mol. Cancer Ther. 2007, 6 (12 Part 1) 3279-86
243. Beedholm-Ebsen, R.; van de Wetering, K.; Hardlei, T.; Nexo, E.; Borst, P.; Moestrup, S. K. Identification of multidrug resistance protein 1 (MRP1/ABCC1) as a molecular gate for cellular export of cobalamin Blood 2010, 115 (8) 1632-9
244. Shen, S.; Callaghan, D.; Juzwik, C.; Xiong, H.; Huang, P.; Zhang, W. ABCG2 reduces ROS-mediated toxicity and inflammation: a potential role in Alzheimer's disease. J. Neurochem. 2010.
245. Rosenberg, M. F.; Bikadi, Z.; Chan, J.; Liu, X.; Ni, Z.; Cai, X.; Ford, R. C.; Mao, Q. The human breast cancer resistance protein (BCRP/ABCG2) shows conformational changes with mitoxantrone Structure 2010, 18 (4) 482-93